期刊文献+

残余肾功能对血液透析患者钙磷代谢状况和死亡率的影响 被引量:1

The effect of residual renal function on calcium-phosphorus metabolism and mortality rate in hemodialysis patients
下载PDF
导出
摘要 目的观察残余肾功能(RRF)对血液透析患者钙磷代谢状况和死亡率的影响。方法 86例血液透析患者按照残肾功能分为2组:透析间期24小时尿量大于200ml,存在RRF(A组);透析间期24小时尿量小于200 ml,RRF丧失(B组)。测定透析前后尿素氮、肌酐、透析间期尿量、透析前血钙磷乘积、血钙、血磷、甲状旁腺激素(PTH)水平。观察1年后两组患者的死亡率。结果 A组患者46例,平均24小时尿量(643±429)ml。血钙水平A组为(2.23±0.63)mmol/L,显著高于B组(1.86±0.49)mmol/L(P<0.05);血磷水平A组为(1.43±0.65)mmol/L,显著低于B组(2.36±1.18)mmol/L(P<0.05);血PTH水平A组为(350.2±123.5)pg/ml),显著低于B组(556.4±167.4)pg/ml(P<0.05)。1年后A组死亡率为11.2%,显著低于B组40.3%(P<0.05)。结论残余肾功能的维持能减轻钙磷代谢异常及继发性甲旁亢,残余肾功能能减少血液透析患者的死亡率。 Objective: To evaluate the effect of residual renal function(RRF) on calcium-phosphorus metabolism and mortality rate in hemodialysis patients.Methods: Eighty six hemodialysis patients were classified into two groups: with RRF(Group A),urine volume200ml/ 24h;without RRF(Group B),urine volume 200 ml/24 h.The impact of RRF on calcium-phosphorus metabolism and mortality rate was examined over a 1-year period.Results: The serum calcium was higher in patients with RRF than that without RRF.The serum phosphorus and PTH were lower in patients with RRF than those without RRF.During that period,the death rate was 11.2% in patients with RRF and 40.3% in patients without RRF(P0.05).RRF was a significant independent predictor of mortality.Conclusion: RRF can slow down calcium-phosphorus metabolism and secondary hyperparathyroidism.The level of RRF is associated with mortality risk in hemodialysis patients.
作者 王蕾
出处 《泰山医学院学报》 CAS 2013年第2期98-100,共3页 Journal of Taishan Medical College
关键词 血液透析 残余肾功能 甲状旁腺激素 死亡率 hemodialysis residual renal function PTH mortality
  • 相关文献

参考文献11

  • 1Shemin D, Andrew GB, Laliberty P, et al. Residual renal function and mortality risk in hemodialysis patients[J]. AmJ Kidney Dis, 2001, 38(1) : 85-90.
  • 2Suda T, Hiroshige K, Ohta T, et al. The contribution of residual renal function to overall nutritional status in chronic haemodialysis patients[J]. Nephrol Dial Transplant, 2000, 15(3): 396?4(B.
  • 3Canada-Usa C. Peritoneal dialysis study group. adequacy of dialysis and nutrition in continuous peritoneal dialysis associated with clini?cal outcomes[J].J Am Soc Nephro, 1996,7: 198-207.
  • 4Moist 1M, Port FK, Orzol SM, et al. Predictors of loss of residual renal function among new dialysis patients[J].J Am Soc Nephrol, 2000, 11 (3) : 556-564.
  • 5Jeremy L,Julie M. Edwina Brown.OXFORD HANDBOOK OF DIALYSIS,王梅主译.牛津临床透析手册[M].北京:人民卫生出版社,2006.104.
  • 6Naves-Dlaz M, Passlick-DeetjenJ, Guinsburg A, et al. Calcium, Phosphorus, PTH and death rates in a large sample of dialysis pa?tients from Latin America. The CORES Study[J]. Nephrol Dial Transplant, 2011, 26(6): 1938-1947.
  • 7Taniguchi MM. (chronic kidney Disease-Mineral and bone disor?der). the impact of CKD-MBD on mortality[J]. Clin Calcium, 2010, 20(7) : 1078-1087.
  • 8Hagstrom E, Hellman P, Larsson TE, et al. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community[J]. Circulation, 2009, 119 (21 ) : 2765 -2771.
  • 9Pontoriero G, Cozzolino M, Locatelli F, et al. CKD patients: the dilemma of serum PTH levels[J]. Nephron Clin Pract, 2010, 116 (4) : c263-c268.
  • 10Stenvinkel P, Alvestrand A. Inflammation in end-stage renal dis?ease: sources, Consequences, and therapy[J] . Semin Dial, 2002, 15(5): 329-337.

共引文献2

同被引文献15

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部